PhenomeX Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
PhenomeX has a total shareholder equity of $111.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $178.3M and $67.1M respectively.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
US$0
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$30.96m |
| Aandelen | US$111.28m |
| Totaal verplichtingen | US$67.05m |
| Totaal activa | US$178.33m |
Recente financiële gezondheidsupdates
Recent updates
Analyst Forecasts Just Became More Bearish On PhenomeX Inc. (NASDAQ:CELL)
May 16
PhenomeX Inc.'s (NASDAQ:CELL) Subdued P/S Might Signal An Opportunity
Apr 17Analysts Just Made A Major Revision To Their Berkeley Lights, Inc. (NASDAQ:BLI) Revenue Forecasts
Aug 15Mehul Joshi joins Berkeley Lights as CFO
Jul 25Berkeley Lights Grows Revenue But Operating Losses Mount
Dec 09Are Investors Undervaluing Berkeley Lights, Inc. (NASDAQ:BLI) By 49%?
Nov 07Berkeley Lights: Short Seller Report Raises A Few Legitimate Questions
Sep 23Berkeley Lights: Optofluidic Technology Presents Strong Upside, May Redefine Therapeutic Development
Jun 09Berkeley Lights Q1 2021 Earnings Preview
May 10Analyse van de financiële positie
Kortlopende schulden: CELL's short term assets ($94.8M) exceed its short term liabilities ($42.2M).
Langlopende schulden: CELL's short term assets ($94.8M) exceed its long term liabilities ($24.8M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: CELL is debt free.
Schuld verminderen: CELL had no debt 5 years ago.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: CELL has less than a year of cash runway based on its current free cash flow.
Voorspelling contante baan: CELL has less than a year of cash runway if free cash flow continues to reduce at historical rates of 26.9% each year